Correlation Between Conduit Pharmaceuticals and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Vertex Pharmaceuticals.
Diversification Opportunities for Conduit Pharmaceuticals and Vertex Pharmaceuticals
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Conduit and Vertex is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Conduit Pharmaceuticals and Vertex Pharmaceuticals
Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 31.17 times more return on investment than Vertex Pharmaceuticals. However, Conduit Pharmaceuticals is 31.17 times more volatile than Vertex Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 14.00 in Conduit Pharmaceuticals on September 12, 2024 and sell it today you would lose (12.93) from holding Conduit Pharmaceuticals or give up 92.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 35.56% |
| Values | Daily Returns |
Conduit Pharmaceuticals vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Conduit Pharmaceuticals |
| Vertex Pharmaceuticals |
Conduit Pharmaceuticals and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Conduit Pharmaceuticals and Vertex Pharmaceuticals
The main advantage of trading using opposite Conduit Pharmaceuticals and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Conduit Pharmaceuticals vs. Equillium | Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Valneva SE ADR | Conduit Pharmaceuticals vs. Vivani Medical |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |